Co-Diagnostics, Inc.

Co-Diagnostics, Inc. is a molecular diagnostics company specializing in real-time PCR (polymerase chain reaction) testing platforms and assays for infectious disease detection. The company develops and manufactures PCR instruments, test kits, and diagnostic solutions for clinical, research, and vector control applications. Core product lines include the Co-Dx PCR Pro platform (an on-site PCR instrument for point-of-care and home testing), the Co-Dx Box (a compact qPCR cycler), and the Logix Smart® assay line covering COVID-19, tuberculosis, influenza, RSV, HPV, and other infectious diseases. Co-Dx also offers research-use-only (RUO) products for laboratory applications and specialized Vector Smart™ PCR tests for mosquito abatement and vector control professionals. The company markets its solutions to at-home consumers, healthcare providers, clinical laboratories, enterprises, and vector control agencies. Technology differentiators include proprietary Co-Primers® technology (which reduces primer dimer propagation) and multiplex PCR capabilities enabling simultaneous detection of multiple pathogens. Products are available as FDA-cleared or Emergency Use Authorized (EUA) in vitro diagnostics (IVD) where regulatory approvals have been obtained. The company maintains ISO 13485:2016 certification for quality management systems.